National

Head-on crash in B.C. Interior kills three

Darpan News Desk The Canadian Press, 06 Jul, 2022 12:03 PM

CHASE, B.C. - RCMP are investigating a head-on crash in British Columbia's Shuswap region that left three people dead.

A statement from Chase RCMP says police were called to an area along the Trans-Canada Highway near Sorrento Tuesday afternoon.

It says all the occupants of both vehicles died at the scene.

Police say witnesses report a black sedan crossed into the path of an oncoming westbound SUV, hitting it head on.

The RCMP say the crash killed a 51-year-old Sorrento man, a 67-year old woman and a 60-year-old man, both from Blind Bay.

The BC Coroners Service and police continue to investigate.

Prev Next

MORE National ARTICLES

Fish processing plant to close in Surrey, B.C.

Fisheries Minister Joyce Murray could not immediately be reached for comment but said last month she plans to ensure the decision to phase out 19 open-net pen farms from the Discovery Islands is carried on to completion.

Fish processing plant to close in Surrey, B.C.

Copy-cat fear after Texas synagogue hostage siege

Toronto police have also increased patrols around synagogues and other Jewish community buildings, although they have said there is no known threat at this time.

Copy-cat fear after Texas synagogue hostage siege

Winter storm pummels large stretch of Ontario

Environment Canada issued snowfall, winter storm or blizzard warnings for a stretch of the province spanning from the Cornwall area to the east, the Algonquin region to the west, and the Niagara and London regions to the south.

Winter storm pummels large stretch of Ontario

China Omicron claim on Canada 'ludicrous': expert

A Chinese state-controlled news outlet first reported that the Jan. 7 infection of a Beijing resident was the result of receiving a letter or parcel from Canada that passed through Hong Kong.

China Omicron claim on Canada 'ludicrous': expert

Health Canada approves Pfizer COVID-19 drug

The agency authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers or on patients who are already hospitalized because of COVID-19

Health Canada approves Pfizer COVID-19 drug

Pfizer antiviral approved in Canada

The authorization posted to the Health Canada website Monday morning says the treatment can be used for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.